Gut microbial short-chain fatty acids and the risk of diabetes

Gut microbial short-chain fatty acids and the risk of diabetes

Play all audios:

Loading...

A new study used genome-wide association data and Mendelian randomization to investigate associations between the gut microbiome and metabolic traits. The researchers demonstrate that host


genetic variants influence levels of the short-chain fatty acids butyrate and propionate in the gut, which in turn modulate host glycaemic metabolism. Access through your institution Buy or


subscribe This is a preview of subscription content, access via your institution RELEVANT ARTICLES Open Access articles citing this article. * ASSOCIATION BETWEEN ANTIBIOTICS USE AND


DIABETES INCIDENCE IN A NATIONALLY REPRESENTATIVE RETROSPECTIVE COHORT AMONG KOREANS * Sun Jae Park * , Young Jun Park *  … Sang Min Park _Scientific Reports_ Open Access 04 November 2021 *


GUT MICROBIOTA DYSBIOSIS CONTRIBUTES TO THE DEVELOPMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE * Naijian Li * , Zhouli Dai *  … Pixin Ran _Respiratory Research_ Open Access 25 October 2021


* CHRONIC EXPOSURE TO AMBIENT PARTICULATE MATTER INDUCES GUT MICROBIAL DYSBIOSIS IN A RAT COPD MODEL * Naijian Li * , Zhaowei Yang *  … Pixin Ran _Respiratory Research_ Open Access 19


October 2020 ACCESS OPTIONS Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days


cancel any time Learn more Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink *


Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional


subscriptions * Read our FAQs * Contact customer support REFERENCES * Lau, W. L. et al. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. _Clin.


Sci._ 132, 509–522 (2018). Article  CAS  Google Scholar  * Canfora, E. E. et al. Gut microbial metabolites in obesity, NAFLD and T2DM. _Nat. Rev. Endocrinol._


https://doi.org/10.1038/s41574-019-0156-z (2019). * Sanna, S. et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. _Nat. Genet._


https://doi.org/10.1038/s41588-019-0350-x (2019). * Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. _Nature_ 562, 589–594 (2018). Article 


CAS  PubMed  PubMed Central  Google Scholar  * de Goffau, M. C. et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. _Diabetes_ 62,


1238–1244 (2013). Article  PubMed  PubMed Central  Google Scholar  * Zhao, L. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. _Science_ 359, 1151–1156


(2018). Article  CAS  PubMed  Google Scholar  * Evans, D. M. & Davey Smith, G. Mendelian randomization: new applications in the coming age of hypothesis-free causality. _Annu. Rev.


Genomics Hum. Genet._ 16, 327–350 (2015). Article  CAS  PubMed  Google Scholar  * Wong, J. et al. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of


short-chain fatty acid-producing intestinal microbiota in ESRD. _Am. J. Nephrol._ 39, 230–237 (2014). Article  CAS  PubMed  Google Scholar  Download references ACKNOWLEDGEMENTS W.L.L. is


funded by American Heart Association grant 17IRG33410803 and National Institutes of Health–National Institute of Neurological Disorders and Stroke grant R01 NS20989. AUTHOR INFORMATION


AUTHORS AND AFFILIATIONS * Division of Nephrology, Department of Medicine, University of California, Irvine, CA, USA Wei Ling Lau & Nosratola D. Vaziri Authors * Wei Ling Lau View author


publications You can also search for this author inPubMed Google Scholar * Nosratola D. Vaziri View author publications You can also search for this author inPubMed Google Scholar


CORRESPONDING AUTHORS Correspondence to Wei Ling Lau or Nosratola D. Vaziri. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. RIGHTS AND PERMISSIONS


Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Lau, W.L., Vaziri, N.D. Gut microbial short-chain fatty acids and the risk of diabetes. _Nat Rev Nephrol_ 15, 389–390 (2019).


https://doi.org/10.1038/s41581-019-0142-7 Download citation * Published: 27 March 2019 * Issue Date: July 2019 * DOI: https://doi.org/10.1038/s41581-019-0142-7 SHARE THIS ARTICLE Anyone you


share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the


Springer Nature SharedIt content-sharing initiative